Letters

Lipid lowering drugs in diabetes: Absolute risk reduction is what counts

BMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7552.1272-a (Published 25 May 2006) Cite this as: BMJ 2006;332:1272
  1. L S Lewis, general practitioner (sam@garthnewydd.freeserve.co.uk)
  1. Surgery, Newport, Pembrokeshire SA42 0TJ

    EDITOR—Costa et al draw the principal conclusion that diabetic patients benefit more, in both primary and secondary prevention.1 But it is abundantly clear from their own analysis that the relative risk reduction was …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe